The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.
The FDA approving a new non-opioid painkiller, meaning it does not carry the risk of addiction.
Readers and medical professionals discuss the Trump administration halting communication and travel at HHS. Regarding the Jan ...
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.
The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
The Lay’s potato chips recall for undeclared milk was upgraded to the FDA’s highest risk level. Find out what this means for ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
The FDA just set the highest risk level—class 1—for the recall of Lay's Classic Potato Chips amid concern that they contain ...